Samples for COVID-19 testing (Photo: VNA) Hanoi (VNA) – The domestically-transmitted COVID-19 cases in Vietnamhas risen to 3,072, with 30 patients confirmed in the past 12 hours as of 6amon May 19, the Ministry of Health said.
Of them, 16 were recorded in Bac Ninh province, 10 in Bac Giang, three in LangSon and one in Ho Chi Minh City.
The ministry also documented one imported case on the morning, bringing thetotal imported infections to 1,471.
As many as 1,502 COVID-19 patients were confirmed in the nation since it washit by the fourth COVID-19 wave on April 27.
A total of 121,010 people who came in close contact with COVID-19 patients orarrived from pandemic-hit areas are being quarantined nationwide, including2,217 at hospitals, 32,348 at other quarantine sites, and 86,445 at residences.
Among the COVID-19 patients, 37 have tested negative for the SARS-CoV-2 once,29 twice, and 23 thrice.
More than one million COVID-19vaccine shots were given to frontline medical workers and members ofcommunity-based anti-COVID-19 groups in Vietnam as of 4pm on May 18. Thecountry began its COVID-19 inoculation campaign on March 8.
The Ministry of Health said that Vietnam will receive 31 million Pfizer vaccinedoses in Quarter III and Quarter IV.
According to Health Minister Nguyen ThanhLong, his ministry has spared no efforts to seek vaccine sources for thenation, and around 110 million doses will be supplied for Vietnam this year,38.9 million doses of which are from COVAX Facility, 30 million fromAstraZeneca, and 31 million from Pfizer/BioNTech.
Furthermore, the ministry has registered to buy additional 10 million dosesthrough COVAX under the cost share mechanism.
Negotiations are underway to purchase more vaccines from Moderna,Johnson&Johnson, CureVac, Spunik V and Sinopharm, helping diversify vaccinesources to serve the locals, he added.
Currently, four Vietnamese vaccines are under development, produced by NagogenPharmaceutical Biotechnology JSC, the Institute of Vaccines and MedicalBiologicals (IVAC), Vaccine and Biological Production Company No. 1 (Vabiotech)and the Center for Research and Production of Vaccines and Biologicals(Polyvac)./.
VNA
